Saffron Pharma

What Saffron Pharma does

Saffron Pharma (Pvt.) Ltd. is a privately held Pakistani pharmaceutical manufacturer headquartered in Faisalabad. Founded in 1997 as a marketing company, it has evolved into an integrated manufacturer with cGMP-compliant facilities producing oral solid dosage forms, topical preparations, and parenteral products, plus a dedicated Cephalosporin Plant. Its stated differentiator is the application of proprietary drug delivery technologies to develop innovative medicines, though no specific patents or technology disclosures are listed in the available materials.

The company markets a broad portfolio of approximately 80+ SKUs across at least 15 therapeutic categories, including antibiotics (Sonnet ceftriaxone, Lucid ciprofloxacin, Locus levofloxacin, Sefkin amikacin, Azotek), anti-diabetics (Alosita sitagliptin, Bygliv vildagliptin and metformin combinations), cardiovascular drugs (Prestor, Sar-K Plus, Hypotin, Safcor, Rostor), gastrointestinal products (Esofil, Noctis, Apsin, Daxolanz), corticosteroids (Hivate, Provate), antihistamines (Cetrix), antifungals (Terbisil), analgesics/NSAIDs (Sofac, Mobirom, Pirexen), vitamins and supplements (Acefer, Bezel, Doplet-3), and hormonal products. The portfolio combines established generic molecules (e.g., esomeprazole, omeprazole, diclofenac) with branded formulations and pediatric suspensions.

Saffron's commercial model is a traditional pharmaceutical wholesale distribution approach, with a national distribution setup covering all of Pakistan and reaching every suburb. The company serves patients and healthcare providers, with revenue mechanics tied to volume sales through wholesalers and pharmacies rather than subscriptions, licensing, or direct-to-patient channels. Leadership comprises CEO Zia ul Haq and Managing Director Yash Patel. The company has no disclosed funding rounds, no institutional investors, no subsidiaries, and no announced M&A or partnership activity in the source data, suggesting a privately held, organically funded operating model.

Name

Saffron Pharma

Legal name

Saffron Pharma (Pvt.) Ltd.

Website

https://saffronpharma.com

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Saffron Pharma is a privately held Pakistani pharmaceutical manufacturer founded in 1997, headquartered in Faisalabad, producing a broad multi-therapeutic portfolio of branded generics across antibiotics, anti-diabetics, cardiovascular, and other categories, distributed nationally to Pakistani healthcare providers.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Specialty Care Pharmaceuticals (HLAIAAAB)

akta.pro secondary industries

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA), Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity) (HLAIAAAE)

Keywords

• Pharmaceutical manufacturing
• Generic medicines
• Cephalosporin antibiotics
• Drug delivery technologies
• Oral solid dosage forms

Headquarters

HQ city

Faisalabad

HQ country

Pakistan

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Distribution channels1 record

Marketing channels2 records

Core offering

Saffron Pharma is a Pakistani pharmaceutical manufacturer that develops and markets innovative medicines across multiple therapeutic categories including antibiotics, anti-diabetics, cardiovascular, gastrointestinal, corticosteroids, dermatology, antihistamines, antifungals, vitamins, analgesics, bronchodilators, and hormonal products. It operates cGMP-compliant Main Plant and Cephalosporin Plant facilities producing oral solid dosage forms, topical preparations, and parenteral products, with proprietary drug delivery technologies applied to product development. The company distributes nationally across Pakistan to healthcare providers and patients.

Product overview

Saffron Pharma is a Pakistani pharmaceutical company developing and marketing innovative medicines across multiple therapeutic categories. The company operates a cGMP-compliant manufacturing facility producing oral solid dosage forms, topical preparations, and parenteral products. The product portfolio spans antibiotics (Azotek, Sonnet, Lucid, Locus, Sefkin), anti-diabetics (Alosita, Bygliv, Safgo-Met), cardiovascular medications (Prestor, Sar-K Plus, Hypotin, Safcor, Rostor), gastrointestinal drugs (Esofil, Noctis, Daxolanz), corticosteroids (Hivate, Provate), dermatologicals (Cosmin Gel, Clear), antihistamines (Cetrix), antifungals (Terbisil), vitamins and supplements (Acefer, Bezel, Doplet-3), and various other therapeutic areas including analgesics, bronchodilators, and hormonal products. The company was established in 1997 as a marketing company and has grown to serve healthcare needs throughout Pakistan.

Differentiator

Problem solved

Functional benefit

Products and services

• Azotek 500 mg Antibiotic medication for treating bacterial infections, listed by Saffron Pharma as part of its antibiotic product category.
• Cyprodiol Oral Tablets Oral tablets for hormonal treatment, listed by Saffron Pharma in the Hormonal Products category.
• Daxolanz Capsule Capsule medication for gastrointestinal conditions, listed by Saffron Pharma in the Gastrointestinal category.
• Doplet-3 Injection Vitamin injection supplement listed by Saffron Pharma in the Vitamin category.
• Hivate Corticosteroid Range Mometasone corticosteroid offered by Saffron Pharma across cream, ointment, nasal spray, and topical steroid forms for treating eczema, psoriasis, allergies, and rash.
• Prestor Tablet Combination of amlodipine and valsartan for treating high blood pressure (hypertension), listed in the Anti-Hypertensive category.
• Provate Topical Corticosteroid Range Betamethasone-based corticosteroid cream and ointment marketed by Saffron Pharma for treating eczema, dermatitis, allergies, and rash.
• Provate-G Topical Corticosteroid + Antimicrobial Range Topical corticosteroid cream and ointment for relief of inflammatory manifestations of corticosteroid-responsive dermatoses when complicated by secondary infection.
• Terbisil Antifungal Range Terbinafine antifungal medication offered as 125mg and 250mg formulations by Saffron Pharma for treating certain fungal infections.
• Sonnet Cephalosporin Injection Range Ceftriaxone injection belonging to cephalosporin antibiotics, offered in 250mg, 500mg, 1g, I.V 250mg, I.V 500mg, and 2GIV presentations for treating bacterial infections.
• Alosita Sitagliptin medication belonging to DPP-4 inhibitors class for controlling high blood sugar in type 2 diabetes.
• Alosita-Met Combination of metformin and sitagliptin for controlling blood sugar levels in type 2 diabetes.
• Bygliv Vildagliptin antidiabetic medication for controlling blood sugar levels in type 2 diabetes mellitus.
• Bygliv-Met Combination Range Combination of vildagliptin and metformin for improving glycemic control in type 2 diabetes, offered in 50/850mg and 50/1000mg strengths.
• Cosmin Anti-Acne Range Topical acne treatment products marketed as Cosmin Gel and Cosmin A for treating acne by unblocking pores and treating blackheads or whiteheads.
• Cetrix Antihistamine Range Cetirizine Hydrochloride syrup and 10mg tablets for relieving allergy symptoms such as watery eyes, runny nose, itching, sneezing, and hives.
• Sar-K Plus Tablet Combination of Losartan Potassium and Hydrochlorothiazide for treating essential hypertension.
• Clear Adapalene Acne Range Adapalene cream for treating acne, decreasing number and severity of pimples, offered in 0.1% and 0.3% strengths.
• Rostor 5mg Rosuvastatin statin medication for lowering bad cholesterol and raising good cholesterol.
• Joyel Escitalopram SSRI antidepressant for treating major depressive disorder and anxiety.
• Normiron Injection Iron injection supplement.
• Esofil Esomeprazole Range Esomeprazole proton pump inhibitor capsules in 20mg and 40mg for treating ulcers.
• Apsin 40mg Tablet Famotidine H2 receptor antagonist for treating and preventing GI ulcers and GERD.
• Noctis Omeprazole Range Omeprazole proton pump inhibitor offered as 20mg capsules for oral use and 40mg injection for intravenous use, for treating peptic, duodenal, and gastric ulcers.
• Higab 75mg Capsules Pregabalin anticonvulsant for treating fibromyalgia, diabetic neuropathy, and partial onset seizures.
• Bezel Injection Vitamin B12 injection for treating deficiency, anemia, fatigue, and numbness.
• Acefer Iron Supplement Range Iron supplement syrup and Acefer-F (Iron + Folic Acid) tablets for treating iron deficiency anemia, preventing deficiency during pregnancy, and reducing constipation side effects.
• Lucid Ciprofloxacin Range Ciprofloxacin quinolone antibiotic offered as 250mg tablets, 500mg tablets, and 400mg/100ml infusion for treating bacterial infections.
• Locus Levofloxacin Range Levofloxacin fluoroquinolone antibiotic offered in tablet form and infusion form for treating pneumonia, sinusitis, bronchitis, and skin infections.
• Godicef Pediatric Antibiotic Range Antibiotic suspension in 100mg and 200mg strengths marketed by Saffron Pharma for pediatric use.
• Hypotin 5mg Tablets Amlodipine calcium channel blocker for treating high blood pressure and angina.
• Sar-K Tablet 50mg Losartan angiotensin receptor blocker for treating hypertension and protecting kidneys from diabetes damage.
• Safcor 5mg Tablet Bisoprolol beta blocker for treating high blood pressure.
• Naldol Injection Nadolol beta blocker injection for treating high blood pressure and preventing angina.
• Vabrin 5mg Heart failure medication that makes the heart work more efficiently by lowering heart rate.
• Sefkin Amikacin Range Amikacin aminoglycoside antibiotic injection offered in 100mg, 250mg, and 500mg per 2ml strengths for treating gram-negative bacterial infections.
• Amorob Suspension Metronidazole antibiotic suspension for treating serious bacterial infections and preventing bowel infections before surgery.
• Fucort Ointment Antibacterial ointment for clearing skin infections.
• Microcid 400mg Tablets Moxifloxacin quinolone antibiotic tablet for treating bacterial infections.
• Gemi 320mg Tablets Gemifloxacin antibiotic tablets for treating bacterial infections.
• Sofac Diclofenac Range Diclofenac NSAID family offered as 50mg tablet, Sofac-P, Sofac-SR (extended release), Sofac-M, Sofac Gel (topical), and Sofac Injection for pain relief, joint and muscle conditions.
• Trifort Tramadol Hydrochloride / Paracetamol tablets for symptomatic treatment of moderate to severe pain.
• Sokast 4mg Sachet Montelukast leukotriene inhibitor sachet for preventing asthma attacks and treating allergies.
• Muscolin Thiocolchicoside Range Thiocolchicoside muscle relaxant offered as 4mg/2ml injection and 4mg capsules for treating painful muscle contractures, back pain, and spinal disorders.
• Mobirom 8mg Tablets Lornoxicam NSAID for treating mild to moderate pain, rheumatoid arthritis, and osteoarthritis.
• Pirexen 20mg Tablets Piroxicam NSAID for reducing pain, swelling, and joint stiffness from arthritis.
• Namet 50mg Tablets Clomiphene Citrate for treating ovulatory failure in women desiring pregnancy.
• Imunol Ointment Topical ointment for treating symptoms of eczema when other medications cannot be used.
• Xenocit Pharmaceutical Range Pharmaceutical syrup and tablet marketed by Saffron Pharma.
• Rupasaf Specs Pediatric antibiotic suspension.
• Zolara Tablet Hormonal medication tablet.
• Saffron Pharma Manufacturing Facilities Pharmaceutical manufacturing service organization encompassing the Main Plant and Cephalosporin Plant, operating under current Good Manufacturing Practice compliance with integrated Quality Control, Quality Assurance, and Research & Development functions.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Getz Pharma: One of the largest private-sector Pakistani pharmaceutical companies manufacturing and marketing branded generics across cardiovascular, anti-infectives, and CNS — the closest scale and business-model comparable to Saffron in the domestic market.
• Hilton Pharma: Pakistani private pharma company with comparable therapeutic breadth (anti-infectives, cardiovascular, gastroenterology), national distribution, and a similar founder-owned operating profile.
• The Searle Company Limited: PSX-listed Pakistani pharmaceutical company with overlapping branded-generic portfolio across cardiovascular, anti-diabetic, anti-infectives, and consumer health — directly competes with Saffron on similar molecules and prescriber base.
• Ferozsons Laboratories Limited: Listed Pakistani pharma with manufacturing in oral solids and a branded-generic portfolio in hepatitis, anti-infectives, and cardiology; competes in the same Pakistani prescription market and distribution channels.
• AGP Limited: One of Pakistan's largest pharma manufacturers with a strong branded generics portfolio, large-scale cGMP manufacturing, and similar national distribution coverage — a direct head-to-head competitor in multiple therapeutic categories.
• Highnoon Laboratories Limited: Pakistani listed pharma with comparable branded-generic positioning and a portfolio spanning cardiovascular, anti-infectives, and pain management — directly competes for prescriber share in Pakistan.
• Sami Pharmaceuticals (Pvt.) Limited: Karachi-headquartered Pakistani pharma manufacturer with a similar branded-generic business model and overlap in cardiovascular and anti-infective therapeutic areas where Saffron competes.

Broad incumbents

• GlaxoSmithKline Pakistan Limited: Multinational pharma subsidiary operating broadly across therapeutic categories in Pakistan; offers overlapping branded products but as part of a wider global portfolio rather than specializing in domestic branded generics.
• Abbott Laboratories Pakistan: Subsidiary of global healthcare major with established presence in Pakistan across pharmaceuticals, nutritionals, and diagnostics; competes with Saffron in anti-infectives, gastroenterology, and cardiovascular categories but operates as part of a global portfolio.
• Sanofi Pakistan: Multinational pharmaceutical subsidiary operating in Pakistan with branded products across multiple therapeutic areas including cardiovascular and anti-infectives, providing competitive overlap with Saffron's portfolio from a broader global platform.

Market position

Strengths5 records

Weaknesses2 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xtwitter.com/saffronpharma
• Facebookfacebook.com/saffronpharma
• LinkedInlinkedin.com/company/saffron-pharma

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Saffron Pharma